Ms. Rubina Mulchandani | Epidemiology | Best Researcher Award

Indian Institute of Public Health-Delhi-India

Author Profile

• Scopus Profile
• Orcid Profile
• Google Scholar Profile

Early Academic Pursuits

Rubina Mulchandani began her academic journey with a B.Sc. in Life Sciences from Hansraj College, Delhi University, where she excelled, achieving a rank of 3 at the university level and securing the top position in her college. This early success was a testament to her commitment and aptitude for science. Following her undergraduate studies, she pursued a Master’s in Clinical Research from the Indian Institute of Public Health (PHFI) and AcSIR, graduating in July 2016 with a commendable CGPA of 9.00. This advanced education laid a solid foundation for her future research endeavors and her specialization in clinical research.

Professional Endeavors

Rubina’s professional career spans a variety of roles that showcase her dedication to the field of clinical research and public health. She started as a Lecturer at Lady Doak College and later held positions as an Assistant Professor at New Prince Shri Bhavani College of Engineering and Technology, and Madras Christian College. In 2019, she joined Anna University as a Teaching Fellow, where she continues to contribute to the academic and research community. Her roles have included designing and implementing epidemiological research studies, data analysis using applied statistics, and managing complex research projects. Rubina’s ability to handle diverse responsibilities underscores her expertise in the field.

Contributions and Research Focus

Rubina’s research has primarily focused on epidemiology and clinical research, with a special emphasis on the impact of statin use on neuro-cognitive functions. Her postgraduate thesis investigated the prevalence of myopathy and other adverse effects of statins among adult users. This project involved comprehensive responsibilities, including literature review, project proposal development, ethical clearances, and data analysis. Her current Ph.D. thesis, titled “Statin Use Related Neuro-Cognitive Changes Among Adults,” is a longitudinal pilot study that further explores these effects at a large tertiary care hospital in Delhi. Additionally, Rubina has made significant contributions to physical activity research, analyzing its impact on cardiovascular diseases and conducting systematic reviews and meta-analyses.

Accolades and Recognition

Rubina Mulchandani has garnered considerable recognition throughout her career. She was selected as a finalist for the Saransh Thesis Presentation Competition 2023 and has been featured on the podcast “Halftime Scholars” in December 2022. Her talk titled “Epidemiology for Kids” was delivered at the India Science Festival, reflecting her commitment to science communication. Rubina was awarded the CSIR-Senior Research Fellowship in February 2021 and was interviewed by the News Hour BBC UK for her contributions as a woman scientist during the COVID-19 pandemic. She has also been acknowledged for her participation in various prestigious events, such as the Novartis Biotechnology Leadership Camp and the Indian Society for Clinical Research Conference.

Impact and Influence

Rubina’s work has significantly influenced the field of epidemiology and clinical research. Her research on statin use and neuro-cognitive changes contributes to a better understanding of the side effects of widely used medications, potentially guiding future clinical practices and patient care strategies. Her teaching and workshops have helped educate health professionals and postgraduate students, spreading knowledge on epidemiology, biostatistics, and medical writing. Rubina’s involvement in public science communication and her achievements in research competitions highlight her impact on both the scientific community and the general public.

Legacy and Future Contributions

Rubina Mulchandani’s legacy is built on her dedication to advancing clinical research and public health. Her research has already paved the way for deeper insights into medication side effects and has set a high standard for future studies. As she continues her Ph.D. thesis and engages in teaching and public outreach, her future contributions are likely to further enrich the fields of epidemiology and clinical research. Rubina’s efforts in educating the next generation of researchers and her ongoing research promise to have a lasting impact on both scientific knowledge and public health practices.